Trump administration proposes ways to lower some U.S. drug costs: WSJ

Published 02/09/2018, 11:41 AM
Updated 02/09/2018, 11:50 AM
© Reuters. FILE PHOTO - Bottles of medications line the shelves at a pharmacy in Portsmouth

WASHINGTON (Reuters) - The Trump administration is proposing ways to curb the cost of prescription drugs for seniors and other Americans, the Wall Street Journal reported on Friday, acting on repeated pledges by President Donald Trump to tackle rising prices.

Health and Human Services Secretary Alex Azar, who was sworn in last month, plans to include the drug pricing initiatives in Trump's budget proposal, which will be released on Monday, the Journal reported.

The reforms Azar laid out include making generic drugs free for seniors and introducing a cap on what seniors pay each year for expensive medicines under the government's Medicare program for the elderly, the report said.

The administration will also propose allowing Medicaid, the government health insurance program for the poor, the ability to exclude some prescription medications from their list of approved drugs in an effort to negotiate lower prices with drugmakers.

© Reuters. FILE PHOTO - Bottles of medications line the shelves at a pharmacy in Portsmouth

HHS did not immediately respond to a request for comment.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.